Astrid Franke

1.8k total citations
28 papers, 1.0k citations indexed

About

Astrid Franke is a scholar working on Genetics, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Astrid Franke has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 6 papers in Surgery. Recurrent topics in Astrid Franke's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Astrid Franke is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Astrid Franke collaborates with scholars based in Germany, United States and Switzerland. Astrid Franke's co-authors include Kathleen Jentsch‐Ullrich, Martin Mohren, Wolfgang Knauf, Michael Herold, Michael Koenigsmann, Mathias Freund, Gottfried Dölken, C. Klinkenstein, E. Kettner and Antje Haas and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Astrid Franke

27 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Franke Germany 13 641 403 392 154 143 28 1.0k
James W. Lynch United States 16 660 1.0× 458 1.1× 283 0.7× 149 1.0× 186 1.3× 34 1.1k
Biljana Mihaljević Serbia 15 687 1.1× 417 1.0× 289 0.7× 115 0.7× 164 1.1× 103 1.1k
Igor Aurer Croatia 20 531 0.8× 449 1.1× 223 0.6× 187 1.2× 159 1.1× 88 950
Livio Gargantini Italy 19 563 0.9× 396 1.0× 311 0.8× 85 0.6× 193 1.3× 31 1.1k
Silvia Franceschetti Italy 17 751 1.2× 366 0.9× 422 1.1× 161 1.0× 245 1.7× 47 1.3k
Fadhela Bouafia France 15 818 1.3× 668 1.7× 333 0.8× 255 1.7× 181 1.3× 24 1.5k
Felicitas Hitz Switzerland 17 669 1.0× 560 1.4× 230 0.6× 190 1.2× 195 1.4× 63 1.1k
D.P. Deakin United Kingdom 21 755 1.2× 449 1.1× 284 0.7× 294 1.9× 236 1.7× 40 1.2k
Alessia Bari Italy 19 550 0.9× 449 1.1× 179 0.5× 119 0.8× 147 1.0× 53 911
Mars B. van ’t Veer Netherlands 15 536 0.8× 356 0.9× 284 0.7× 198 1.3× 140 1.0× 36 1.4k

Countries citing papers authored by Astrid Franke

Since Specialization
Citations

This map shows the geographic impact of Astrid Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Franke more than expected).

Fields of papers citing papers by Astrid Franke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Franke. The network helps show where Astrid Franke may publish in the future.

Co-authorship network of co-authors of Astrid Franke

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Franke. A scholar is included among the top collaborators of Astrid Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Franke. Astrid Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franke, Astrid, et al.. (2022). Reading the Social in American Studies.
3.
Jentsch‐Ullrich, Kathleen, Andrea Wagner, Matthias Hammwöhner, et al.. (2007). G‐CSF‐Induced Mobilization of CD34+ Progenitor Cells and Proarrhythmic Effects in Patients with Severe Coronary Artery Disease. Pacing and Clinical Electrophysiology. 30(s1). S166–9. 13 indexed citations
6.
Schalk, Enrico, Martin Mohren, Kathleen Jentsch‐Ullrich, et al.. (2006). Zygomycoses in patients with acute leukaemia. Annals of Hematology. 85(5). 327–32. 10 indexed citations
7.
Goette, Andreas, Kathleen Jentsch‐Ullrich, Matthias Hammwöhner, et al.. (2006). Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy. EP Europace. 8(3). 157–160. 4 indexed citations
8.
Koenigsmann, Michael, et al.. (2005). Subjektive Krankheitsvorstellungen bei Patienten mit akuter Leukämie eine Woche nach Diagnosestellung/ Illness Perceptions of Patients Suffering from Acute Leukaemia One Week after Diagnosis. Zeitschrift für psychosomatische Medizin und Psychotherapie. 51(4). 388–402. 4 indexed citations
9.
Schalk, Enrico, Martin Mohren, Michael Koenigsmann, et al.. (2005). Metastatic Adrenal Neuroblastoma in an Adult. Oncology Research and Treatment. 28(6-7). 353–355. 7 indexed citations
10.
Mohren, Martin, et al.. (2004). Thromboembolic complications after splenectomy for hematologic diseases. American Journal of Hematology. 76(2). 143–147. 84 indexed citations
11.
Jentsch‐Ullrich, Kathleen, Holger Braun, Michael Koenigsmann, et al.. (2004). Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib.. PubMed. 89(5). ECR15–ECR15. 31 indexed citations
12.
Schmitt, Johannes, et al.. (2003). Thymic Hyperplasia following Successful Treatment for Nodular-sclerosing Hodgki n's Disease. Leukemia & lymphoma. 44(9). 1615–1617. 12 indexed citations
13.
Mohren, Martin, et al.. (2003). Acute Myelofibrosis in a Patient with Diffuse Large Cell Non Hodgki n's Lymphoma and Renal Cancer. Leukemia & lymphoma. 44(9). 1603–1607. 4 indexed citations
14.
Schmitt, Barbara, Astrid Franke, Oswald Burkhard, et al.. (2002). Fludarabine, Mitoxantrone and Cyclophosphamide Combination Therapy in Relapsed Chronic Lymphocytic Leukemia with or without G-CSF Results of the First Interim Ananlysis of a Phase III Study of the German CLL Study Group. Blood. 100(11). 501516. 3 indexed citations
15.
Röcken, Christoph, et al.. (2002). Pulmonary low-grade MALT-lymphoma associated with localized pulmonary amyloidosis. A case report. Amyloid. 9(3). 190–193. 14 indexed citations
16.
Schmitt, Barbara, Clemens‐Martin Wendtner, Michael Bergmann, et al.. (2002). Fludarabine Combination Therapy for the Treatment of Chronic Lymphocytic Leukemia. Clinical Lymphoma. 3(1). 26–35. 19 indexed citations
17.
Hallek, Michael, Barbara Schmitt, Martin Wilhelm, et al.. (2001). Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. British Journal of Haematology. 114(2). 342–348. 93 indexed citations
18.
Röcken, Christoph, et al.. (2000). Rosai-Dorfman disease and generalized AA amyloidosis: A case report. Human Pathology. 31(5). 621–624. 19 indexed citations
19.
Lendeckel, Uwe, et al.. (1998). Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing. Human Mutation. 11(S1). S158–S160. 5 indexed citations
20.
Franke, Astrid, et al.. (1996). Effects of normovolemic and hypervolemic hematocrit variations on muscle tissue oxygen pressure in patients with chronic ischemia of the calf muscle. Clinical Hemorheology and Microcirculation. 16(3). 249–265. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026